Europe Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Blood Component Volume (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Immunosuppression (Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others), Oncology (Hematologic Malignancies and Solid Tumor Patients), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care during Chemotherapy, Surgery, and Others), Age Group (Adult and Child), and End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others)
The Europe Donor Blood Component Market is projected to grow significantly, reaching an estimated US$ 3,464.5 million by 2031, up from US$ 2,420.0 million in 2024, reflecting a compound annual growth rate (CAGR) of 5.4% from 2025 to 2031. This growth is driven by several factors, including an aging population, advancements in medical technology, and increased awareness of the importance of blood donation.
Market Overview
The market is segmented by country, including Germany, the UK, France, Italy, Spain, and the Rest of Europe. The aging demographic in Europe has led to a heightened demand for blood components, primarily due to the rising prevalence of chronic diseases, surgical procedures, and age-related health issues. Innovations in transfusion medicine and blood component separation technologies have enhanced the efficiency and safety of blood processing and storage, further supporting market growth.
Government initiatives promoting voluntary blood donation have also played a crucial role in increasing donor participation. The rising incidence of trauma cases and cancer treatments necessitates a reliable blood supply, which is critical for effective patient care. Stringent regulations and established standards for blood component handling have fostered trust among healthcare providers and patients, ensuring high-quality blood products are available when needed.
Strategic Insights
The Europe Donor Blood Component Market is categorized by various factors:
The increasing prevalence of cancer and immunosuppressive diseases is a significant driver for the demand for blood components, particularly platelets and plasma. Patients undergoing chemotherapy or immunosuppressive treatments often require frequent transfusions, which is a key factor propelling the market forward. The global cancer incidence is projected to rise, with estimates suggesting over 28.4 million new cases annually by 2040, further increasing the demand for blood components in treatment settings.
Additionally, the aging population is more susceptible to cancer and immunosuppressive disorders, necessitating a secure and reliable blood supply. This growing clinical need underscores the importance of continuous blood donation and advanced blood processing technologies. Healthcare institutions and blood banks are enhancing their capabilities to meet this rising demand, which is crucial for the sustainability of the donor blood component market.
Country Insights
Germany is the leading country in the Europe Donor Blood Component Market, driven by its aging population and the demand for blood components in managing chronic diseases, oncology, and surgical procedures. The Federal Statistical Office (Destatis) projects that by 2030, 22% of Germany's population will be aged 65 and over, further escalating the need for blood components.
Germany has a well-structured blood donation system, primarily managed by the German Red Cross (GRC), which accounts for about 70% of blood donations. The GRC operates multiple blood transfusion services and donation centers, ensuring a steady supply of blood. State-run agencies contribute an additional 20%, while private centers account for the remaining 10%. This organized system facilitates blood donations and promotes a culture of giving, supported by social campaigns in various public venues.
In 2020, Germany recorded 44 whole-blood donations and 33 apheresis donations per 1,000 inhabitants. The demand for donor blood is further amplified by the increasing number of organ transplants, which require substantial blood transfusions due to the invasive nature of these procedures. The interplay of demographic changes, strategic donor engagement, and rising medical demand is driving market growth in Germany.
Key Players
Key players in the Europe Donor Blood Component Market include Vitalant, Memorial Sloan Kettering Cancer Center, Roswell Park Comprehensive Cancer Center, Policlinico of Milan, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, and Tata Memorial Hospital. These organizations are focusing on expansion, product innovation, and strategic mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
Market Overview
The market is segmented by country, including Germany, the UK, France, Italy, Spain, and the Rest of Europe. The aging demographic in Europe has led to a heightened demand for blood components, primarily due to the rising prevalence of chronic diseases, surgical procedures, and age-related health issues. Innovations in transfusion medicine and blood component separation technologies have enhanced the efficiency and safety of blood processing and storage, further supporting market growth.
Government initiatives promoting voluntary blood donation have also played a crucial role in increasing donor participation. The rising incidence of trauma cases and cancer treatments necessitates a reliable blood supply, which is critical for effective patient care. Stringent regulations and established standards for blood component handling have fostered trust among healthcare providers and patients, ensuring high-quality blood products are available when needed.
Strategic Insights
The Europe Donor Blood Component Market is categorized by various factors:
- By Blood Component: The market is divided into Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others. Red Blood Cells are expected to maintain the largest market share in 2024.
- By Indication: The market is segmented into Immunosuppression and Oncology, with Immunosuppression holding the largest share in 2024.
- By Immunosuppression: This includes categories such as Organ Transplant, HIV/AIDS, Autoimmune Diseases, and Cardiovascular Surgeries, with HIV/AIDS being the most significant segment.
- By Oncology: The market is divided into Hematologic Malignancies and Solid Tumor Patients, with Hematologic Malignancies leading in market share.
- By Application: Applications include Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, and Supportive Care during Chemotherapy, with Anemia Management being the largest segment.
- By Age Group: The market is segmented into Adult and Child, with Adults dominating the market.
- By End User: The primary end users are Hospitals, Oncology Centers, Transplant Centers, and Ambulatory Surgical Centers, with Hospitals holding the largest share.
The increasing prevalence of cancer and immunosuppressive diseases is a significant driver for the demand for blood components, particularly platelets and plasma. Patients undergoing chemotherapy or immunosuppressive treatments often require frequent transfusions, which is a key factor propelling the market forward. The global cancer incidence is projected to rise, with estimates suggesting over 28.4 million new cases annually by 2040, further increasing the demand for blood components in treatment settings.
Additionally, the aging population is more susceptible to cancer and immunosuppressive disorders, necessitating a secure and reliable blood supply. This growing clinical need underscores the importance of continuous blood donation and advanced blood processing technologies. Healthcare institutions and blood banks are enhancing their capabilities to meet this rising demand, which is crucial for the sustainability of the donor blood component market.
Country Insights
Germany is the leading country in the Europe Donor Blood Component Market, driven by its aging population and the demand for blood components in managing chronic diseases, oncology, and surgical procedures. The Federal Statistical Office (Destatis) projects that by 2030, 22% of Germany's population will be aged 65 and over, further escalating the need for blood components.
Germany has a well-structured blood donation system, primarily managed by the German Red Cross (GRC), which accounts for about 70% of blood donations. The GRC operates multiple blood transfusion services and donation centers, ensuring a steady supply of blood. State-run agencies contribute an additional 20%, while private centers account for the remaining 10%. This organized system facilitates blood donations and promotes a culture of giving, supported by social campaigns in various public venues.
In 2020, Germany recorded 44 whole-blood donations and 33 apheresis donations per 1,000 inhabitants. The demand for donor blood is further amplified by the increasing number of organ transplants, which require substantial blood transfusions due to the invasive nature of these procedures. The interplay of demographic changes, strategic donor engagement, and rising medical demand is driving market growth in Germany.
Key Players
Key players in the Europe Donor Blood Component Market include Vitalant, Memorial Sloan Kettering Cancer Center, Roswell Park Comprehensive Cancer Center, Policlinico of Milan, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, and Tata Memorial Hospital. These organizations are focusing on expansion, product innovation, and strategic mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. DONOR BLOOD COMPONENT MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024
4.4 Global Disease Prevalence of 5 Key Diseases, 2024
5. EUROPE DONOR BLOOD COMPONENT MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. DONOR BLOOD COMPONENT MARKET - EUROPE MARKET ANALYSIS
6.1 Europe Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
6.2 Europe Donor Blood Component Market Forecast and Analysis
7. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY BLOOD COMPONENT
7.1 Red Blood Cells
7.1.1 Overview
7.1.2 Red Blood Cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 White blood cells
7.2.1 Overview
7.2.2 White blood cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Platelets
7.3.1 Overview
7.3.2 Platelets: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Plasma
7.4.1 Overview
7.4.2 Plasma: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY BLOOD COMPONENT VOLUME
8.1 Red Blood Cells
8.1.1 Overview
8.1.2 Red Blood Cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 White blood cells
8.2.1 Overview
8.2.2 White blood cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Platelets
8.3.1 Overview
8.3.2 Platelets: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Plasma
8.4.1 Overview
8.4.2 Plasma: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY INDICATION
9.1 Immunosuppression
9.1.1 Overview
9.1.2 Immunosuppression: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oncology
9.2.1 Overview
9.2.2 Oncology: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY IMMUNOSUPPRESSION
10.1 Organ Transplant
10.1.1 Overview
10.1.2 Organ Transplant: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 HIV or AIDS
10.2.1 Overview
10.2.2 HIV or AIDS: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Autoimmune Disease
10.3.1 Overview
10.3.2 Autoimmune Disease: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Cardiovascular Surgeries
10.4.1 Overview
10.4.2 Cardiovascular Surgeries: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 Orthopedic Surgeries
10.5.1 Overview
10.5.2 Orthopedic Surgeries: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY ONCOLOGY
11.1 Hematologic malignancies
11.1.1 Overview
11.1.2 Hematologic malignancies: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Solid Tumor Patients
11.2.1 Overview
11.2.2 Solid Tumor Patients: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY APPLICATION
12.1 Anemia management
12.1.1 Overview
12.1.2 Anemia management: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Thrombocytopenia treatment
12.2.1 Overview
12.2.2 Thrombocytopenia treatment: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Coagulopathy correction
12.3.1 Overview
12.3.2 Coagulopathy correction: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.4 Supportive care during chemotherapy
12.4.1 Overview
12.4.2 Supportive care during chemotherapy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.5 Surgery
12.5.1 Overview
12.5.2 Surgery: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.6 Others
12.6.1 Overview
12.6.2 Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY AGE GROUP
13.1 Adult
13.1.1 Overview
13.1.2 Adult: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Child
13.2.1 Overview
13.2.2 Child: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY END USER
14.1 Hospitals
14.1.1 Overview
14.1.2 Hospitals: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Oncology centers
14.2.1 Overview
14.2.2 Oncology centers: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Transplant centers
14.3.1 Overview
14.3.2 Transplant centers: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.4 Ambulatory surgical centers
14.4.1 Overview
14.4.2 Ambulatory surgical centers: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.5 Others
14.5.1 Overview
14.5.2 Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. EUROPE DONOR BLOOD COMPONENT MARKET - COUNTRY ANALYSIS
15.1 Europe
15.1.1 Europe Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.1.1 Europe Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.2.2 Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 Germany: Europe Donor Blood Component Market Share - by Blood Component
15.1.2.2.2 Germany: Europe Donor Blood Component Market Share - by Blood Component Volume
15.1.2.2.3 Germany: Europe Donor Blood Component Market Share - by Indication
15.1.2.2.4 Germany: Europe Donor Blood Component Market Share - by Immunosuppression
15.1.2.2.5 Germany: Europe Donor Blood Component Market Share - by Oncology
15.1.2.2.6 Germany: Europe Donor Blood Component Market Share - by Application
15.1.2.2.7 Germany: Europe Donor Blood Component Market Share - by Age Group
15.1.2.2.8 Germany: Europe Donor Blood Component Market Share - by End User
15.2.3.3 United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 United Kingdom: Europe Donor Blood Component Market Share - by Blood Component
15.2.3.3.2 United Kingdom: Europe Donor Blood Component Market Share - by Blood Component Volume
15.2.3.3.3 United Kingdom: Europe Donor Blood Component Market Share - by Indication
15.2.3.3.4 United Kingdom: Europe Donor Blood Component Market Share - by Immunosuppression
15.2.3.3.5 United Kingdom: Europe Donor Blood Component Market Share - by Oncology
15.2.3.3.6 United Kingdom: Europe Donor Blood Component Market Share - by Application
15.2.3.3.7 United Kingdom: Europe Donor Blood Component Market Share - by Age Group
15.2.3.3.8 United Kingdom: Europe Donor Blood Component Market Share - by End User
15.3.4.4 France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 France: Europe Donor Blood Component Market Share - by Blood Component
15.3.4.4.2 France: Europe Donor Blood Component Market Share - by Blood Component Volume
15.3.4.4.3 France: Europe Donor Blood Component Market Share - by Indication
15.3.4.4.4 France: Europe Donor Blood Component Market Share - by Immunosuppression
15.3.4.4.5 France: Europe Donor Blood Component Market Share - by Oncology
15.3.4.4.6 France: Europe Donor Blood Component Market Share - by Application
15.3.4.4.7 France: Europe Donor Blood Component Market Share - by Age Group
15.3.4.4.8 France: Europe Donor Blood Component Market Share - by End User
15.4.5.5 Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.4.5.5.1 Spain: Europe Donor Blood Component Market Share - by Blood Component
15.4.5.5.2 Spain: Europe Donor Blood Component Market Share - by Blood Component Volume
15.4.5.5.3 Spain: Europe Donor Blood Component Market Share - by Indication
15.4.5.5.4 Spain: Europe Donor Blood Component Market Share - by Immunosuppression
15.4.5.5.5 Spain: Europe Donor Blood Component Market Share - by Oncology
15.4.5.5.6 Spain: Europe Donor Blood Component Market Share - by Application
15.4.5.5.7 Spain: Europe Donor Blood Component Market Share - by Age Group
15.4.5.5.8 Spain: Europe Donor Blood Component Market Share - by End User
15.5.6.6 Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.5.6.6.1 Italy: Europe Donor Blood Component Market Share - by Blood Component
15.5.6.6.2 Italy: Europe Donor Blood Component Market Share - by Blood Component Volume
15.5.6.6.3 Italy: Europe Donor Blood Component Market Share - by Indication
15.5.6.6.4 Italy: Europe Donor Blood Component Market Share - by Immunosuppression
15.5.6.6.5 Italy: Europe Donor Blood Component Market Share - by Oncology
15.5.6.6.6 Italy: Europe Donor Blood Component Market Share - by Application
15.5.6.6.7 Italy: Europe Donor Blood Component Market Share - by Age Group
15.5.6.6.8 Italy: Europe Donor Blood Component Market Share - by End User
15.6.7.7 Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.6.7.7.1 Rest of Europe: Europe Donor Blood Component Market Share - by Blood Component
15.6.7.7.2 Rest of Europe: Europe Donor Blood Component Market Share - by Blood Component Volume
15.6.7.7.3 Rest of Europe: Europe Donor Blood Component Market Share - by Indication
15.6.7.7.4 Rest of Europe: Europe Donor Blood Component Market Share - by Immunosuppression
15.6.7.7.5 Rest of Europe: Europe Donor Blood Component Market Share - by Oncology
15.6.7.7.6 Rest of Europe: Europe Donor Blood Component Market Share - by Application
15.6.7.7.7 Rest of Europe: Europe Donor Blood Component Market Share - by Age Group
15.6.7.7.8 Rest of Europe: Europe Donor Blood Component Market Share - by End User
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Vitalant
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Memorial Sloan Kettering Cancer Center
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 Roswell Park Comprehensive Cancer Center
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 Policlinico of Milan
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 MD Anderson Cancer Center.
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 The Johns Hopkins Hospital
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 The Royal Marsden
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Gustave Roussy
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Peter MacCallum Cancer Centre
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
18.10 Tata Memorial Hospital
18.10.1 Key Facts
18.10.2 Business Description
18.10.3 Products and Services
18.10.4 Financial Overview
18.10.5 SWOT Analysis
18.10.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. DONOR BLOOD COMPONENT MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024
4.4 Global Disease Prevalence of 5 Key Diseases, 2024
5. EUROPE DONOR BLOOD COMPONENT MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. DONOR BLOOD COMPONENT MARKET - EUROPE MARKET ANALYSIS
6.1 Europe Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
6.2 Europe Donor Blood Component Market Forecast and Analysis
7. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY BLOOD COMPONENT
7.1 Red Blood Cells
7.1.1 Overview
7.1.2 Red Blood Cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 White blood cells
7.2.1 Overview
7.2.2 White blood cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Platelets
7.3.1 Overview
7.3.2 Platelets: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Plasma
7.4.1 Overview
7.4.2 Plasma: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY BLOOD COMPONENT VOLUME
8.1 Red Blood Cells
8.1.1 Overview
8.1.2 Red Blood Cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 White blood cells
8.2.1 Overview
8.2.2 White blood cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Platelets
8.3.1 Overview
8.3.2 Platelets: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Plasma
8.4.1 Overview
8.4.2 Plasma: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY INDICATION
9.1 Immunosuppression
9.1.1 Overview
9.1.2 Immunosuppression: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oncology
9.2.1 Overview
9.2.2 Oncology: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY IMMUNOSUPPRESSION
10.1 Organ Transplant
10.1.1 Overview
10.1.2 Organ Transplant: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 HIV or AIDS
10.2.1 Overview
10.2.2 HIV or AIDS: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Autoimmune Disease
10.3.1 Overview
10.3.2 Autoimmune Disease: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Cardiovascular Surgeries
10.4.1 Overview
10.4.2 Cardiovascular Surgeries: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 Orthopedic Surgeries
10.5.1 Overview
10.5.2 Orthopedic Surgeries: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY ONCOLOGY
11.1 Hematologic malignancies
11.1.1 Overview
11.1.2 Hematologic malignancies: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Solid Tumor Patients
11.2.1 Overview
11.2.2 Solid Tumor Patients: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY APPLICATION
12.1 Anemia management
12.1.1 Overview
12.1.2 Anemia management: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Thrombocytopenia treatment
12.2.1 Overview
12.2.2 Thrombocytopenia treatment: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Coagulopathy correction
12.3.1 Overview
12.3.2 Coagulopathy correction: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.4 Supportive care during chemotherapy
12.4.1 Overview
12.4.2 Supportive care during chemotherapy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.5 Surgery
12.5.1 Overview
12.5.2 Surgery: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.6 Others
12.6.1 Overview
12.6.2 Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY AGE GROUP
13.1 Adult
13.1.1 Overview
13.1.2 Adult: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Child
13.2.1 Overview
13.2.2 Child: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. EUROPE DONOR BLOOD COMPONENT MARKET REVENUE ANALYSIS - BY END USER
14.1 Hospitals
14.1.1 Overview
14.1.2 Hospitals: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Oncology centers
14.2.1 Overview
14.2.2 Oncology centers: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Transplant centers
14.3.1 Overview
14.3.2 Transplant centers: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.4 Ambulatory surgical centers
14.4.1 Overview
14.4.2 Ambulatory surgical centers: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.5 Others
14.5.1 Overview
14.5.2 Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. EUROPE DONOR BLOOD COMPONENT MARKET - COUNTRY ANALYSIS
15.1 Europe
15.1.1 Europe Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.1.1 Europe Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.2.2 Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 Germany: Europe Donor Blood Component Market Share - by Blood Component
15.1.2.2.2 Germany: Europe Donor Blood Component Market Share - by Blood Component Volume
15.1.2.2.3 Germany: Europe Donor Blood Component Market Share - by Indication
15.1.2.2.4 Germany: Europe Donor Blood Component Market Share - by Immunosuppression
15.1.2.2.5 Germany: Europe Donor Blood Component Market Share - by Oncology
15.1.2.2.6 Germany: Europe Donor Blood Component Market Share - by Application
15.1.2.2.7 Germany: Europe Donor Blood Component Market Share - by Age Group
15.1.2.2.8 Germany: Europe Donor Blood Component Market Share - by End User
15.2.3.3 United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 United Kingdom: Europe Donor Blood Component Market Share - by Blood Component
15.2.3.3.2 United Kingdom: Europe Donor Blood Component Market Share - by Blood Component Volume
15.2.3.3.3 United Kingdom: Europe Donor Blood Component Market Share - by Indication
15.2.3.3.4 United Kingdom: Europe Donor Blood Component Market Share - by Immunosuppression
15.2.3.3.5 United Kingdom: Europe Donor Blood Component Market Share - by Oncology
15.2.3.3.6 United Kingdom: Europe Donor Blood Component Market Share - by Application
15.2.3.3.7 United Kingdom: Europe Donor Blood Component Market Share - by Age Group
15.2.3.3.8 United Kingdom: Europe Donor Blood Component Market Share - by End User
15.3.4.4 France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 France: Europe Donor Blood Component Market Share - by Blood Component
15.3.4.4.2 France: Europe Donor Blood Component Market Share - by Blood Component Volume
15.3.4.4.3 France: Europe Donor Blood Component Market Share - by Indication
15.3.4.4.4 France: Europe Donor Blood Component Market Share - by Immunosuppression
15.3.4.4.5 France: Europe Donor Blood Component Market Share - by Oncology
15.3.4.4.6 France: Europe Donor Blood Component Market Share - by Application
15.3.4.4.7 France: Europe Donor Blood Component Market Share - by Age Group
15.3.4.4.8 France: Europe Donor Blood Component Market Share - by End User
15.4.5.5 Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.4.5.5.1 Spain: Europe Donor Blood Component Market Share - by Blood Component
15.4.5.5.2 Spain: Europe Donor Blood Component Market Share - by Blood Component Volume
15.4.5.5.3 Spain: Europe Donor Blood Component Market Share - by Indication
15.4.5.5.4 Spain: Europe Donor Blood Component Market Share - by Immunosuppression
15.4.5.5.5 Spain: Europe Donor Blood Component Market Share - by Oncology
15.4.5.5.6 Spain: Europe Donor Blood Component Market Share - by Application
15.4.5.5.7 Spain: Europe Donor Blood Component Market Share - by Age Group
15.4.5.5.8 Spain: Europe Donor Blood Component Market Share - by End User
15.5.6.6 Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.5.6.6.1 Italy: Europe Donor Blood Component Market Share - by Blood Component
15.5.6.6.2 Italy: Europe Donor Blood Component Market Share - by Blood Component Volume
15.5.6.6.3 Italy: Europe Donor Blood Component Market Share - by Indication
15.5.6.6.4 Italy: Europe Donor Blood Component Market Share - by Immunosuppression
15.5.6.6.5 Italy: Europe Donor Blood Component Market Share - by Oncology
15.5.6.6.6 Italy: Europe Donor Blood Component Market Share - by Application
15.5.6.6.7 Italy: Europe Donor Blood Component Market Share - by Age Group
15.5.6.6.8 Italy: Europe Donor Blood Component Market Share - by End User
15.6.7.7 Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.6.7.7.1 Rest of Europe: Europe Donor Blood Component Market Share - by Blood Component
15.6.7.7.2 Rest of Europe: Europe Donor Blood Component Market Share - by Blood Component Volume
15.6.7.7.3 Rest of Europe: Europe Donor Blood Component Market Share - by Indication
15.6.7.7.4 Rest of Europe: Europe Donor Blood Component Market Share - by Immunosuppression
15.6.7.7.5 Rest of Europe: Europe Donor Blood Component Market Share - by Oncology
15.6.7.7.6 Rest of Europe: Europe Donor Blood Component Market Share - by Application
15.6.7.7.7 Rest of Europe: Europe Donor Blood Component Market Share - by Age Group
15.6.7.7.8 Rest of Europe: Europe Donor Blood Component Market Share - by End User
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Vitalant
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Memorial Sloan Kettering Cancer Center
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 Roswell Park Comprehensive Cancer Center
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 Policlinico of Milan
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 MD Anderson Cancer Center.
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 The Johns Hopkins Hospital
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 The Royal Marsden
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Gustave Roussy
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Peter MacCallum Cancer Centre
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
18.10 Tata Memorial Hospital
18.10.1 Key Facts
18.10.2 Business Description
18.10.3 Products and Services
18.10.4 Financial Overview
18.10.5 SWOT Analysis
18.10.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
LIST OF TABLES
Table 1. Europe Donor Blood Component Market Segmentation
Table 3. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 5. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 6. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 7. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 8. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 9. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 11. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 12. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 14. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 15. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 16. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 17. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 18. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 20. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 22. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 23. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 24. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 25. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 26. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 27. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 28. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 30. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 31. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 32. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 33. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 34. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 35. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 36. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 37. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 38. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 39. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 40. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 41. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 42. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 43. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 44. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 45. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 46. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 47. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 48. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 49. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 50. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 51. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 52. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 53. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 54. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 55. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 56. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 57. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 58. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 59. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 60. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 1. Europe Donor Blood Component Market Segmentation
Table 3. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 5. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 6. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 7. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 8. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 9. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 11. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 12. Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 14. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 15. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 16. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 17. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 18. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 20. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 22. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 23. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 24. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 25. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 26. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 27. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 28. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 30. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 31. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 32. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 33. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 34. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 35. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 36. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 37. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 38. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 39. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 40. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 41. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 42. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 43. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 44. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 45. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 46. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 47. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 48. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 49. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 50. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 51. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 52. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 53. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 54. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 55. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 56. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 57. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 58. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 59. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 60. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
LIST OF FIGURES
Figure 1. Europe Donor Blood Component Market Segmentation - Country
Figure 4. Europe Donor Blood Component Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
Figure 7. Europe Donor Blood Component Market Share (%) - by Blood Component, 2024 and 2031
Figure 8. Red Blood Cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. White blood cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Platelets: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Plasma: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Europe Donor Blood Component Market Share (%) - by Blood Component Volume, 2024 and 2031
Figure 14. Red Blood Cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. White blood cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Platelets: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Plasma: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Europe Donor Blood Component Market Share (%) - by Indication, 2024 and 2031
Figure 20. Immunosuppression: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Oncology: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Europe Donor Blood Component Market Share (%) - by Immunosuppression, 2024 and 2031
Figure 23. Organ Transplant: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. HIV or AIDS: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Autoimmune Disease: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Cardiovascular Surgeries: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Orthopedic Surgeries: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Europe Donor Blood Component Market Share (%) - by Oncology, 2024 and 2031
Figure 30. Hematologic malignancies: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Solid Tumor Patients: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Europe Donor Blood Component Market Share (%) - by Application, 2024 and 2031
Figure 33. Anemia management: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Thrombocytopenia treatment: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Coagulopathy correction: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Supportive care during chemotherapy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Surgery: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Europe Donor Blood Component Market Share (%) - by Age Group, 2024 and 2031
Figure 40. Adult: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Child: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Europe Donor Blood Component Market Share (%) - by End User, 2024 and 2031
Figure 43. Hospitals: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 44. Oncology centers: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Transplant centers: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Ambulatory surgical centers: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 48. Europe Donor Blood Component Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 49. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 52. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 1. Europe Donor Blood Component Market Segmentation - Country
Figure 4. Europe Donor Blood Component Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
Figure 7. Europe Donor Blood Component Market Share (%) - by Blood Component, 2024 and 2031
Figure 8. Red Blood Cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. White blood cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Platelets: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Plasma: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Europe Donor Blood Component Market Share (%) - by Blood Component Volume, 2024 and 2031
Figure 14. Red Blood Cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. White blood cells: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Platelets: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Plasma: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Europe Donor Blood Component Market Share (%) - by Indication, 2024 and 2031
Figure 20. Immunosuppression: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Oncology: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Europe Donor Blood Component Market Share (%) - by Immunosuppression, 2024 and 2031
Figure 23. Organ Transplant: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. HIV or AIDS: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Autoimmune Disease: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Cardiovascular Surgeries: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Orthopedic Surgeries: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Europe Donor Blood Component Market Share (%) - by Oncology, 2024 and 2031
Figure 30. Hematologic malignancies: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Solid Tumor Patients: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Europe Donor Blood Component Market Share (%) - by Application, 2024 and 2031
Figure 33. Anemia management: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Thrombocytopenia treatment: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Coagulopathy correction: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Supportive care during chemotherapy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Surgery: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Europe Donor Blood Component Market Share (%) - by Age Group, 2024 and 2031
Figure 40. Adult: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Child: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Europe Donor Blood Component Market Share (%) - by End User, 2024 and 2031
Figure 43. Hospitals: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 44. Oncology centers: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Transplant centers: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Ambulatory surgical centers: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Others: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 48. Europe Donor Blood Component Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 49. Germany: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. United Kingdom: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. France: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 52. Spain: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. Italy: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. Rest of Europe: Europe Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
